期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

人16型乳头瘤病毒“假病毒”免疫保护作用的研究 被引量：2

Immunity of human papillomavirus type 16 pseudovirions
下载PDF
导出
摘要 目的评价构建的人16型乳头瘤病毒“假病毒”的免疫保护作用。方法利用杆状病毒表达系统在sf9昆虫细胞中表达组装了人16型乳头瘤病毒病毒样颗粒,将病毒样颗粒解聚后与真核表达质粒混合,重聚集成“假病毒”。用这种“假病毒”对小鼠进行免疫保护作用研究。结果小鼠经“假病毒”免疫后,可以在血清中检测到特异性的IgG,在阴道分泌物中检测到特异性的IgA,脾淋巴细胞可以检测特异性的CTL活性。结论“假病毒” Objective To estimate the immunity of human papillomavints type 16 pseudovirions. Methods Baculovirus-derived HPV16 VIPs were purified and disassembled. After mix with the E7-pcDNA3.1 ＋ plasmids, the disassembled VLPs were reassemble. The VLPs, in which E7-pcDNA3.1 ＋ plasmids were packed, were named pseudovirions. The immunity of the pseudovirions was studied by mice test. Results The pseudovirions immunization could induced production of specific IgG, IgA, and CILs in mice. Conclusion Immunization of mice with HPV16 pseudovirions can elicit antibodies and CTLs
作者 秦焱 崔红莲 胡美浩
机构地区 北京大学生命科学学院生物化学与分子生物学系
出处 《免疫学杂志》 CAS CSCD 北大核心 2006年第6期623-625,共3页 Immunological Journal
关键词 人16型乳头瘤病毒 假病毒 IGG IGA 细胞毒T淋巴细胞反应 Human papillomavirus type 16 Pseudovirions IgG IgA Cytotoxic T lymphocyte
分类号 R392 [医药卫生—免疫学]
  • 相关文献

参考文献13

  • 1Pisani P,Bray F,Parkin DM.Estimates of the world-wide prevalence of cancer for 25 sites in the adult population[J].Int J Cancer,2002,97(1):72-81.
  • 2zur Hausen H.Papillomavirus infections-a major cause of human cancers.[J] Biochim Biophys Acta,1996,1288(2):F55-F78.
  • 3zur Hausen H.Papillomaviruses causing cancer:evasion from host-cell control in early events in carcinogenesis[J].J Natl Cancer Inst,2000,92(2):690-698.
  • 4Qin Y,Wang XH,Cui HL,et al.Human papillomavirus type 16 E7 peptide (38-61) linked with an immunoglobulin G fragment provides protective immunity in mice[J].Gynecol Oncol,2005,96 (2):475-483.
  • 5Volpers C,Unckell F,Schirmacher P,et al.Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells[J].J Virol,1995,69(6):3 258-3 264.
  • 6Evander M,Frazer IH,Payne E,et al.Identification of the alpha 6 integrin as a candidate receptor for papillomaviruses[J].J Virol,1997,71(3):2 449-2 456.
  • 7Kawana Y,Kawana K,Yoshikawa H,et al.Human papillomavirus type 16 minor capsid protein L2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm[J].J Virol,2001,75(5):2 331-2 336.
  • 8Munger K,Phelps WC,Bubb V,et al.The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes[J].J Virol,1989,63(10):4 417-4 421.
  • 9von Knebel Doeberitz M,Rittmuller C,zur Hausen H,et al.Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6-E7 anti-sense RNA[J].Int J Cancer,1992,51(5):831-834.
  • 10Brandtzaeg P.Overview of the mucosal immune system[J].Curr Top Microbiol Immunol,1989,146:13-25.

同被引文献20

  • 1徐道华,夏永鹏,邱宗荫.子宫颈癌治疗性疫苗研究进展[J].免疫学杂志,2004,20(z1):46-49. 被引量：4
  • 2Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer[J]. N Engl J Med, 2003, 348 (6) : 518 - 527.
  • 3Jansen KU, Shaw AR. Human papillomavirus vaccines and prevention of cervical cancer[J]. Annu Rev Med, 2004, 55: 319 - 331.
  • 4Steele JC, Mann CH, Rookes S, et al. T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia [ J ]. Br J Cancer, 2005, 25, 93 (2) : 248 - 259.
  • 5Freyschmidt EJ, Alonso A, Hartmann G, et al. Activation of dendritic cells and induction of T cell responses by HPV 16 L1/E7 chimeric virus-like particles are enhanced by CpG ODN or sorbitol[J]. Antivir Ther, 2004, 9 (4) : 479 - 489.
  • 6Kaufmann AM, Nieland J, Schinz M, et al. HPV16 L1E7 chimeric virus-like particles induce specific HLA-restricted T cells in hmnans after in vitro vaccination [ J ]. Int J Cancer, 2001, 15, 92 (2) : 285 - 293.
  • 7Villa LL, Costa RL, Petta CA, et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/ 11/16/18 L1 virus-like particle vaccine through 5 years of follow-up[J]. Br J Cancer, 2006, 95 (11): 1 459- 1 466.
  • 8Pokorna D, Cerovska N, Smahel M, et al. DNA vaccines based on chimeric potyvirus-like particles carrying HPV16 E7 peptide (aa 44-60) [J]. Oncol Rep, 2005, 14 (4): 1 045- 1 053.
  • 9Kuck D, Leder C, Kern A, et al. Efficiency of HPV 16 L1- E7 DNA immunization: influence of cellular localization and capsid assembly[J]. Vaccine, 2006, 24 (15): 2 952- 2965.
  • 10Munger K, Baldwin A, Edwards KM. Mechanisms of human papillomavirus-induced oncogenesis [J]. J Virol, 2004, 78(21) : 11 451 - 11 460.

引证文献2

二级引证文献2

免疫学杂志
2006年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部